| Open Document File Size: 155,07 KBShare Result on Facebook
Company Submission PDUFA Goal Date Schering -Plough Corporation / SCHERING PLOUGH HEALTHCARE PRODUCTS INC / Schering-Plough / / Country United States / / Currency pence / / Event FDA Phase / / IndustryTerm advertising claims / antihistamine products / treatment of nasal symptoms / treatment of allergic rhinitis symptoms / treatment of the nasal symptoms / / MedicalCondition epistaxis / AM/PM PRIOR nasal congestion / prolonged inflammatory reaction / disease / nasal polyps / reflective nasal congestion / nasal congestion / itching / runny nose / both seasonal and perennial allergic rhinitis / allergic rhinitis / seasonal allergic rhinitis / irritation / nasal congestion symptom score / deficiency / MS / infections / / Person Xu Wang / Lydia Gilbert-McClain / LYDIA I GILBERT / GILBERT MCCLAIN / Review Statistical / / Position investigator / Deputy Director Division Memorandum / AM/PM / Physician / Medical Officer / / Product Nasonex / Mometasone Furoate / Background Nasonex® (mometasone furoate) / Introduction Nasonex® (mometasone furoate) / / Technology antibodies / /
SocialTag |
20762 Mometasone Clinical_PREA Pediatric Review